Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice.

Experimental cell research - 15 Nov 2006

Guttinger Maria, Tafi Elisiana, Battaglia Manuela, Coletta Marcello, Cossu Giulio

Abstract excerpt

Cell therapy for muscular dystrophy involves transplantation of either genetically modified autologous cells or normal donor cells that will be rejected unless the host is adequately immune suppressed. The extent of the immune response appears to be mitigated in this case of stem cells, by immune-suppressive and tolerogenic molecules that they release. We previously reported significant morphological and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Vessels
Share to CD4-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mice, Inbred BALB C

Share to Muscle Fibers, Skeletal

Share to Muscular Dystrophy, Animal

Share to Sarcoglycans

Share to Stem Cell Transplantation

Share to Transplantation, Homologous

Source

Identifiers

PMID: 16982052
DOI: 10.1016/j.yexcr.2006.08.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice.PMID 16982052Read ↗

Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of MesoangioblastsSemantic proximity Read ↗

Transplantation of Genetically Corrected Human iPSC-Derived Progenitors in Mice with Limb-Girdle Muscular DystrophySemantic proximity Read ↗

Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophySemantic proximity Read ↗

Stem Cell Transplantation for Muscular Dystrophy: The Challenge of Immune ResponseSemantic proximity Read ↗

Isolation and Characterization of Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy Muscle BiopsiesSemantic proximity Read ↗

Skeletal muscle differentiation of embryonic mesoangioblasts requires pax3 activity.Semantic proximity Read ↗

A New Immunodeficient Mouse Model for Human Myoblast TransplantationSemantic proximity Read ↗

Gene Transfer into Skeletal Muscles by Isogenic MyoblastsSemantic proximity Read ↗

Xenotransplantation of embryonic precursors of human myogenesis for the correction of dystrophinopathy in mice with hereditary muscular dystrophy.Semantic proximity Read ↗

Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.Semantic proximity Read ↗

Bone marrow transplantation attenuates the myopathic phenotype of a muscular mouse model of spinal muscular atrophy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.